(0)
Collaboration With Institute of Oslo University Hospital Will Leverage AI for Novel Tumor Biology Insights
HAMBURG, Germany, May 6, 2021 /PRNewswire/ Indivumed GmbH ( Indivumed ) today announced a joint research collaboration to expand IndivuType by adding digital pathology images and data using cutting-edge technology from the Institute for Cancer Genetics and Informatics ( ICGI ) at Oslo University Hospital, a world leader in the application of Deep Learning and AI in oncology.
By scanning high resolution images of haematoxylin and eosin-stained tumor section slides for all IndivuType cases, Indivumed will be able to leverage an entirely new dimension of data in the coming months. The expansion of IndivuType s digital pathology asset and analysis capacity will allow Indivumed and ICGI to combine the cancer phenotype, as defined by the tumor morphology, with the deep molecular multi-omics characterization of the tumor, resulting in better prognostic and diagnostic algorithm